Emerging treatment options for myelofibrosis: focus on pacritinib
Chow, Vivian, Weissman, Ashley, O'Connell, Casey Lee, Mehrvar, Azim, Akhtari, Mojtaba
Published in OncoTargets and therapy (01.01.2016)
Published in OncoTargets and therapy (01.01.2016)
Get full text
Journal Article
Symptoms adversely impact survival among patients with cancer and unsuspected pulmonary embolism
O'Connell, Casey Lee, Razavi, Pedram A, Liebman, Howard A
Published in Journal of clinical oncology (01.11.2011)
Published in Journal of clinical oncology (01.11.2011)
Get full text
Journal Article
A phase II study of mocetinostat, an oral isotype-selective histone deacetylase (HDAC) inhibitor, in combination with 5-azacitidine in patients with myelodysplastic syndrome (MDS)
Luger, Selina M., O'Connell, Casey Lee, Klimek, Virginia, Cooper, Maureen A., Besa, Emmanuel C., Rossetti, James M., Reid, Gregory K., Humphrey, Rachel, Martell, Robert E., Garcia-Manero, Guillermo
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
First results of a phase 2 study using a 10-day subcutaneous (SC) regimen of the novel hypomethylating agent (HMA) SGI-110 for the treatment of relapsed/refractory acute myeloid leukemia (r/r AML)
Griffiths, Elizabeth A., Kantarjian, Hagop M., Roboz, Gail J., Kropf, Patricia Lamont, O'Connell, Casey Lee, Yee, Karen W. L., Garcia-Manero, Guillermo, Jabbour, Elias, Feldman, Eric Jay, Walsh, Katherine Jean, Rizzieri, David, Stock, Wendy, Lunin, Scott D., Naim, Sue, Choy, Gavin S., Taverna, Pietro, Hao, Yong, Azab, Mohammad, Chung, Woonbok, Issa, Jean-Pierre J.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article